BNP Paribas Financial Markets’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $665K | Buy |
24,203
+24,054
| +16,144% | +$655K | ﹤0.01% | 3599 |
|
|
2026
Q1 | $4.13K | Buy |
149
+147
| +7,350% | +$4.19K | ﹤0.01% | 5340 |
|
|
2025
Q4 | $68 | Sell |
2
-56
| -97% | -$1.8K | ﹤0.01% | 5629 |
|
|
2025
Q3 | $1.49K | Sell |
58
-244
| -81% | -$5.35K | ﹤0.01% | 5194 |
|
|
2025
Q2 | $5.47K | Hold |
302
| – | – | ﹤0.01% | 4951 |
|
|
2025
Q1 | $2.89K | Hold |
302
| – | – | ﹤0.01% | 4937 |
|
|
2024
Q4 | $4.77K | Buy |
+302
| New | +$4.86K | ﹤0.01% | 4935 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$26 | – | 4049 |
|
|
2023
Q4 | $26 | Hold |
3
| – | – | ﹤0.01% | 3976 |
|
|
2023
Q3 | $28 | Hold |
3
| – | – | ﹤0.01% | 3878 |
|
|
2023
Q2 | $37 | Hold |
3
| – | – | ﹤0.01% | 3880 |
|
|
2023
Q1 | $27 | Hold |
3
| – | – | ﹤0.01% | 3806 |
|
|
2022
Q4 | $42 | Hold |
3
| – | – | ﹤0.01% | 3978 |
|
|
2022
Q3 | $67 | Hold |
3
| – | – | ﹤0.01% | 4663 |
|
|
2022
Q2 | $86 | Sell |
3
-3
| -50% | -$69 | ﹤0.01% | 4024 |
|
|
2022
Q1 | $144 | Sell |
6
-71
| -92% | -$1.52K | ﹤0.01% | 4086 |
|
|
2021
Q4 | $2.15K | Buy |
77
+74
| +2,467% | +$2.43K | ﹤0.01% | 3988 |
|
|
2021
Q3 | $136 | Sell |
3
-7
| -70% | -$293 | ﹤0.01% | 3958 |
|
|
2021
Q2 | $485 | Sell |
10
-817
| -99% | -$40.5K | ﹤0.01% | 3981 |
|
|
2021
Q1 | $45.6K | Buy |
827
+164
| +25% | +$10.9K | ﹤0.01% | 3633 |
|
|
2020
Q4 | $48.1K | Buy |
663
+67
| +11% | +$7.86K | ﹤0.01% | 3568 |
|
|
2020
Q3 | $118K | Buy |
596
+407
| +215% | +$102K | ﹤0.01% | 3031 |
|
|
2020
Q2 | $52.8K | Sell |
189
-529
| -74% | -$123K | ﹤0.01% | 3010 |
|
|
2020
Q1 | $128K | Buy |
718
+469
| +188% | +$101K | ﹤0.01% | 3089 |
|
|
2019
Q4 | $61.1K | Sell |
249
-39
| -14% | -$7.18K | ﹤0.01% | 3530 |
|
|
2019
Q3 | $34K | Buy |
288
+5
| +2% | +$756 | ﹤0.01% | 3693 |
|
|
2019
Q2 | $45.8K | Sell |
283
-81
| -22% | -$15.4K | ﹤0.01% | 3473 |
|
|
2019
Q1 | $86.1K | Buy |
+364
| New | +$92.2K | ﹤0.01% | 3215 |
|
|
2018
Q4 | – | Sell |
-47
| Closed | -$13.6K | – | 4167 |
|
|
2018
Q3 | $20.8K | Hold |
47
| – | – | ﹤0.01% | 3404 |
|
|
2018
Q2 | $21.9K | Sell |
47
-234
| -83% | -$124K | ﹤0.01% | 3463 |
|
|
2018
Q1 | $166K | Sell |
281
-2,576
| -90% | -$1.6M | ﹤0.01% | 2902 |
|
|
2017
Q4 | $1.55M | Buy |
2,857
+2,743
| +2,406% | +$1.24M | ﹤0.01% | 1651 |
|
|
2017
Q3 | $47.8K | Sell |
114
-9
| -7% | -$2.76K | ﹤0.01% | 3169 |
|
|
2017
Q2 | $30.4K | Buy |
+123
| New | +$34.6K | ﹤0.01% | 3440 |
|
|
2016
Q1 | – | Sell |
-218
| Closed | -$19.6K | – | 2690 |
|
|
2015
Q4 | $19.6K | Sell |
218
-62
| -22% | -$6.75K | ﹤0.01% | 3293 |
|
|
2015
Q3 | $32.1K | Buy |
280
+180
| +180% | +$31.7K | ﹤0.01% | 3140 |
|
|
2015
Q2 | $23K | Buy |
+100
| New | +$19.3K | ﹤0.01% | 2954 |
|
|
2014
Q3 | – | Sell |
-20
| Closed | -$1.55K | – | 4095 |
|
|
2014
Q2 | $1.55K | Hold |
20
| – | – | ﹤0.01% | 3242 |
|
|
2014
Q1 | $1.27K | Hold |
20
| – | – | ﹤0.01% | 2792 |
|
|
2013
Q4 | $4.53K | Buy |
+20
| New | +$3.64K | ﹤0.01% | 3156 |
|
Other funds holding ASMB
GS
VCM
AAA
VPM
BNP Paribas Financial Markets's ASMB Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Assembly Biosciences (ASMB) stake by 16,144% in Q2 2026, buying an estimated $655K and bringing the position to 24,203 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #3599.
BNP Paribas Financial Markets first reported a position in ASMB in Q4 2013 and has held it in 39 quarters since. The position peaked at $1.55M in Q4 2017. 43 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.
- BNP Paribas Financial Markets held 24,203 shares of Assembly Biosciences worth $665K as of Q2 2026.
- BNP Paribas Financial Markets bought 24,054 Assembly Biosciences shares in Q2 2026, an estimated $655K.
- Assembly Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3599 holding.
- BNP Paribas Financial Markets first reported a position in Assembly Biosciences in Q4 2013 and has held it in 39 quarters since.
- BNP Paribas Financial Markets's Assembly Biosciences position peaked at $1.55M in Q4 2017.
- 43 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.